...
首页> 外文期刊>Cell chemical biology >Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein
【24h】

Inhibition of Flaviviruses by Targeting a Conserved Pocket on the Viral Envelope Protein

机译:通过针对病毒包膜蛋白靶向保守口袋来抑制黄病毒

获取原文
获取原文并翻译 | 示例
           

摘要

Viral envelope proteins are required for productive viral entry and initiation of infection. Although the humoral immune system provides ample evidence for targeting envelope proteins as an antiviral strategy, there are few pharmacological interventions that have this mode of action. In contrast to classical antiviral targets such as viral proteases and polymerases, viral envelope proteins as a class do not have a well-conserved active site that can be rationally targeted with small molecules. We previously identified compounds that inhibit dengue virus by binding to its envelope protein, E. Here, we show that these small molecules inhibit dengue virus fusion and map the binding site of these compounds to a specific pocket on E. We further demonstrate inhibition of Zika, West Nile, and Japanese encephalitis viruses by these compounds, providing pharmacological evidence for the pocket as a target for developing broad-spectrum antivirals against multiple, mosquito-borne flavivirus pathogens.
机译:生物包膜蛋白是生产病毒进入和感染的启动所必需的。虽然体液免疫系统为靶向包膜蛋白提供了充足的证据,但少量有这种作用模式的药理学干预措施。与典型的抗病毒靶(如病毒蛋白酶和聚合酶)相反,作为阶级的病毒包膜蛋白质不具有可以合理靶向小分子的保守的活性位点。我们之前鉴定了通过与其包络蛋白质结合的抑制登革热病毒的化合物,E。在此表明这些小分子抑制了登革热病毒融合并将这些化合物的结合位点映射到E的特定口袋上。我们进一步证明了Zika的抑制,西尼罗河和日本脑炎病毒通过这些化合物,为口袋提供药理学证据作为对多个蚊虫的黄病毒病原体开发广谱抗病患者的目标。

著录项

  • 来源
    《Cell chemical biology》 |2018年第8期|共19页
  • 作者单位

    Department of Microbiology and Immunobiology Harvard Medical School;

    Department of Microbiology and Immunobiology Harvard Medical School;

    Department of Microbiology and Immunobiology Harvard Medical School;

    Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School and Department of Cancer Biology Dana-Farber Cancer Institute;

    Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School and Department of Cancer Biology Dana-Farber Cancer Institute;

    Department of Cancer Biology Department of Oncologic Pathology Blais Proteomics Center Dana-Farber Cancer Institute;

    Department of Microbiology and Immunobiology Harvard Medical School;

    Department of Microbiology and Immunobiology Harvard Medical School;

    Department of Microbiology and Immunobiology Harvard Medical School;

    Department of Microbiology and Immunobiology Harvard Medical School;

    Department of Chemistry and Chemical Biology Northeastern University;

    Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School and Department of Cancer Biology Dana-Farber Cancer Institute;

    Department of Chemistry and Chemical Biology Northeastern University;

    Department of Cancer Biology Department of Oncologic Pathology Blais Proteomics Center Dana-Farber Cancer Institute;

    Department of Biological Chemistry and Molecular Pharmacology Harvard Medical School and Department of Cancer Biology Dana-Farber Cancer Institute;

    Department of Microbiology and Immunobiology Harvard Medical School;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 普通生物学;生物化学;
  • 关键词

    antiviral; inhibitor of viral entry; envelope protein inhibitor; flavivirus inhibitor;

    机译:抗病毒;病毒进入抑制剂;包络蛋白抑制剂;黄病毒抑制剂;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号